MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33555339

about

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma Radiation risk from medical imaging.Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.MRI of hepatocellular carcinoma: an update of current practices.Imaging for the Diagnosis of Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.

P2860

Q28082223-053E5A7C-7B1E-4B31-A500-AC20DB1E09BF Q34152854-619E73D6-3B33-4350-AA18-545AE2311FAE Q34466458-1490438B-0FB9-417E-BC22-4B14F80B0ED0 Q35207736-709D4A35-6C3C-441C-8BA0-1C9B516E71F1 Q35721200-672D3896-EF30-4545-8966-720FA281240E Q38599685-4A90D70E-6755-4BC1-9A82-AD0FD734C7FD Q41022854-9B88BD35-567E-402A-A215-9278C062AA5E Q46086197-12598D02-483B-42E7-BDC4-74FFE400D97E

P2860

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33555339

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@ast

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@en

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@nl

type

label

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@ast

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@en

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@nl

prefLabel

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@ast

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@en

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@nl

P1433

Q33555339-49A0F1C8-5444-4C6A-81B9-83AF7D4B5CD8

P1476

Q33555339-5A2817C8-E597-4BF5-9614-6377FD8D432F

P2093

Q33555339-08262E7F-C473-4A74-B211-3333648DFC06

Q33555339-0EF039D2-63E1-4A96-9CC7-B9F0A98972FF

Q33555339-313374DB-B001-43F8-84EE-00695BFBD4EA

Q33555339-A34445C4-1013-4E25-8D35-D99E562ABE6D

Q33555339-FB3C0560-949E-4C92-A821-7BB8AA2998F9

P2860

Q33555339-111D4808-AA68-42A2-8EE8-71648C68C42E

Q33555339-19E7E3B1-63C9-44AC-B693-8A1914ED0DCC

Q33555339-30DC68A9-F15E-4434-A21A-B2CE2DF86F98

Q33555339-38249D0E-AD91-4660-A936-AA29C8BA2422

Q33555339-41A6E329-01A9-4E5B-ACEE-838BBD7ACEAF

Q33555339-42DBCD57-732F-4133-BEA2-EAF2A756569A

Q33555339-5D5497A7-700E-45F5-994D-36792F067922

Q33555339-5E294224-4930-4C3B-945D-14CAE6287E72

Q33555339-628A67F3-C562-4960-8292-656277229521

Q33555339-750B8E7B-BB51-486E-9D0A-C5A057260400

P304

Q33555339-6A8FEFB8-7888-4B0F-AC7A-22670EDEE034

P31

Q33555339-38A10E47-3EF4-4106-A05C-D55600AB6294

P356

Q33555339-BFE81540-DD61-4F78-B672-46223674D090

P407

Q33555339-147B6BFD-9778-4427-B026-7678AC26A002

P433

Q33555339-971B8DC0-7A73-4BE8-B7B3-058E58548304

P478

Q33555339-548C4F00-C4D0-4272-AC06-8C681041201A

P50

Q33555339-E2E8F07E-7A80-44B9-9759-ECF96D9908B5

P577

Q33555339-E54AF792-4E94-4745-9A8E-E224DC3FBD1C

P5875

Q33555339-B640BB0A-BC2C-443F-96F9-5C8C336A34E5

P698

Q33555339-862F56C4-C5C6-4702-B9CE-FFF0A9A85714

P932

Q33555339-0AB58E31-DD25-4964-AE0A-58437D3DF3E5

P356

P1433

World Journal of Gastroenterology

P1476

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

@en

P2093

Christoph Dueber

http://www.w3.org/2001/XMLSchema#string

Gerd Otto

http://www.w3.org/2001/XMLSchema#string

Karl Friedrich Kreitner

http://www.w3.org/2001/XMLSchema#string

Michael Bernhard Pitton

http://www.w3.org/2001/XMLSchema#string

Sascha Herber

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.

Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.

Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Estimating the world cancer burden: Globocan 2000.

P304

6044-6051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.15.6044

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Roman Kloeckner

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40758178

http://www.w3.org/2001/XMLSchema#string

P698

20027676

http://www.w3.org/2001/XMLSchema#string

P932

2797660

http://www.w3.org/2001/XMLSchema#string